However, binding of programmed death receptor (PD-1) and its ligand (PD-L1) leads to T cell depletion, allowing tumor cells to evade host immune surveillance, resulting in low response rates for immunotherapy multiple tumors. This evidence concerns the gene CD274 and neoplasm.